Synthesis of Nanocomposition of Poly Acrylic Acid/Chitosan Coated-Magnetite Nanoparticles to Investigation of Interaction with BSA and IGG Proteins
Journal: International Journal of Nanomaterials, Nanotechnology and Nanomedicine (Vol.3, No. 1)Publication Date: 2017-04-04
Authors : Hamidreza Shagholani; Sayed Mehdi Ghoreishi;
Page : 027-033
Keywords : Magnetite nanoparticles; Chitosan; Poly (acrylic acid); Albumin; Immunoglobulin G;
Abstract
Among the nanomaterial being applied for treatment and diagnosis field, magnetic NPs especially magnetite phase of iron oxide have been significantly interested due to their natural magnetic properties. In this study, a nanocomposition of poly (acrylic acid) and chitosan with Fe3O4 NPs were prepared in order to investigation for drug delivery systems and plasma protein adsorption. Synthesized NPs were studied by various technics including XRD, TEM, SEM, FT-IR, VSM, DLS, zeta potential and AAS. These NPs have superparamagnetic property that is essential for magnetic NPs to applying in body and drug delivery. Plasma protein adsorption is one of the most important issues for failure of nanocarriers function. In this work, BSA and IgG were used as models of proteins to study adsorption of protein onto NPs by UV-Vis spectroscopy method. Adsorption behavior of NPs for each protein was different. PAA-Fe3O4 NPs represent the lowest albumin adsorption and can be expected that have lower adsorption of protein in the body. The release profile of ascorbic acid from PAA-Fe3O4 NPs represents no sensitivity to pH, and NPs showed approximately same release behavior in pH 7.4 and 5.8.
Other Latest Articles
- Prediction of Enhanced Dimerization inside Dilute Alloy Nanoparticles
- Two Faces of Curcumin; A Molecular Nutrition and an Anti-Cancer Agent
- Monodisperse Water-Stable Sio2- Coated Fluoride Upconversion Nanoparticles with Tunable Shell Thickness
- Reduced Graphene Oxide and Its Natural Counterpart Shungite Carbon
- Highly Monodisperse Chitosan Nanoparticles Prepared by a Combined Triple-Method for Potential Use as Drug Carriers
Last modified: 2018-09-07 14:26:49